(ZH) Yield Curve Inverts Dramatically As Goldman Sees Recession Risks Soaring

Yield Curve Inverts Dramatically As Goldman Sees Recession Risks Soaring

Following this morning's stagflationary signals from a tumble in unemployment (opens window for Fed hawks), surge in earnings (inflationary pressure building), and slump in ISM Manufacturing (production & new orders down, prices paid spiking), the market has been quick to price in a more aggressive Fed this year (now expecting at least 9 more 2bps-rate-hikes by year-end)... but at the same time, pricing in a dramatic rate-cuts in the following year...
The message - loud and clear - is The Fed's anti-inflationary actions will guarantee a recession, and that will ensure rapid de-escalation from The Fed and a return to QE.
While few are mentioning it in public - and President Biden just told us just how awesome he is by gloating over the surge in job gains (which merely represents people being allowed by the government to get their old - pre-COVID-restrictions - jobs back) - but a recession is coming faster than the regular asset-gatherers and commission-rakers would care to admit.
BofA's Michael Hartnett was recently brave enough to state that he expects a recession to strike by H2 2022, and just this morning, no lesser Wall Street giant than Goldman Sachs raises its recession risk for the following year to 38% (with some far more ominous details under the surface of their model)...
On their own, various segments of the curve that have each been relatively reliable recession indicators historically are implying very different probabilities of recession within the next 24 months. This unusually sharp divergence in the probabilities implied by curve segment is another indicator of the unusual structure of the current yield curve: very steep at the front of the curve, but flat/inverted further out.
Combining indicators into a single model unsurprisingly improves the ability to predict recessions and implies that the market is currently pricing recession probabilities that are broadly consistent with the shape of the curve—close to no chance of recession in the next 12 months, but a higher risk of recession (38%) in the following year.
So what does the market say about all this? Nothing good.
The 2s10s spread has collapsed into inversion this morning...
And 5s30s spread is now dramatically inverted...
And 2s30s has inverted for the first time since 2007...
And for all those trying to distract by forcing your attention to the 3M2Y spread's steepness, here is what the yield curve looks like now... and in one year...
Which leaves the 2s10s curve inverted by 50bps in one year according to the forward curve...
Goldman hedges in its conclusion of course, unwilling to scare its AM clients, explaining that their US econ team has also noted that while they see the risk of a US recession this year as higher relative to an average year, a recession if it were to occur would probably be mild by historical standards as the economy lacks major financial imbalances that would exacerbate a slowdown.
Still - a recession is a recession, and you can't be half-pregnant... and even from Goldman's table above, the US equity market is completely decoupled from this risk of recession, blinkered in its desire to keep the dream alive (and offering all those talking heads the constant refrain of "well, how can we be on the verge of recession when stockjs are so closs to record highs?") Do we really need to show you where stocks were in 2000 (ahead of that recession), 2007 (ahead of that recession), and early 2020 (ahead of that recession).

NY Post : Jada’s hair is no joke — but her boyfriend is: Ricky Gervais goes off

Jada’s hair is no joke — but her boyfriend is: Ricky Gervais goes off during set

He would’ve gone for the jugular.

After Will Smith infamously smacked Chris Rock at the 2022 Oscars, Twitter debated whether the incident would’ve happened if Ricky Gervais had been in Rock’s shoes. Well, the British comic recently weighed in, claiming he wouldn’t have mocked Jada Pinkett Smith’s hair loss as Rock had done — but rather would’ve targeted her open relationship.

While performing in London, the 60-year-old “After Life” creator said, “I’ll get it out of the way. I have not got any Will Smith material,” per the Mirror.

Of course, Gervais was referring to the incident that occurred at Sunday’s Academy Awards, when the 53-year-old Best Actor winner smacked Rock, 57, after the comedian made a bald joke about Jada, who’s been open about her ongoing struggle with alopecia.

“I trended when that happened and I was not even there,” added the original “The Office” mastermind, who has hosted the Golden Globes five times but never the Oscars. “People were going, ‘What would have happened if Ricky Gervais had been doing it [hosting the Oscars]?'”

“Well, nothing,” said Gervais, “as I would not have made a joke about his wife’s hair. I would have made a joke about her boyfriend.”

The comedian was likely referring to 50-year-old Jada’s “entanglement” with much younger R&B singer August Alsina, 29, who claimed he had had an intense affair with the actress. After years of rumors flying around about what had actually gone down, Will admitted last September that he and his wife were in an open relationship.

However, Gervais did seem to poke fun at the hair joke following the Academy Award smack when he retweeted an old bit on alopecia from “The Office.”

Many social media users seemed to agree with Gervais, wondering why the “Hancock” actor would strike a comedian over a joke — and not the man who was bedding his partner.

“You can f–k my wife, but keep her name out yo mouth,” mocked one Twitter user.

“Will Smith’s marriage is open to EVERYTHING except jokes,” jeered conservative commentator CJ Pearson on Twitter.

This isn’t the first time Gervais has teased what he’d say if he were to host the Academy Awards. Earlier this week, the Emmy winner posted a scathing mock-Oscars speech on Twitter.

“I’d start with ‘Hello. I hope this show helps cheer up the ordinary people watching at home,'” the comedian sniped. “‘If you’re unemployed for example, take some comfort in the fact that even if you had a job, your salary probably wouldn’t be as much as the goody bag all the actors have just been given.'”

>>> US Research Calls



From: update@briefing.com At: 04/01/22 13:26:27 UTC+2:00
To: Laurent Chekroun (MAKOR CAPITAL MARKET )
Subject: Briefing; CALLS; Research Calls

Briefing.com Logo
01-Apr-22 07:26 ET

TICKER ALERT: CALLS

Research Calls

  • Upgrades:
    • Banco Santander (SAN) upgraded to Outperform from Neutral at Credit Suisse
    • Caixabank (CAIXY) upgraded to Outperform from Neutral at Credit Suisse
    • Centennial Resource Development (CDEV) upgraded to Buy from Hold at Stifel; tgt raised to $11.20
    • Comerica (CMA) upgraded to Neutral from Sell at Goldman; tgt raised to $112
    • Comerica (CMA) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $115
    • Evotec SE (EVO) upgraded to Buy from Neutral at Kempen; tgt $15
    • Tellurian (TELL) upgraded to Outperform from Neutral at Credit Suisse; tgt raised to $8
    • Vertiv (VRT) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $18
  • Downgrades:
    • Amylyx Pharmaceuticals (AMLX) downgraded to Neutral from Buy at Goldman; tgt lowered to $10
    • American Eagle (AEO) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $19
    • BankUnited (BKU) downgraded to Neutral from Overweight at JP Morgan; tgt $50
    • Blend Labs (BLND) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $5
    • Blend Labs (BLND) downgraded to Hold from Buy at Canaccord Genuity; tgt lowered to $5
    • Blend Labs (BLND) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $5.50
    • Commscope (COMM) downgraded to Neutral from Buy at Goldman; tgt lowered to $9
    • Dell (DELL) downgraded to Neutral from Conviction Buy at Goldman; tgt lowered to $61
    • Ellington Residential Mtg (EARN) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
    • First American Financial (FAF) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $74
    • Gap (GPS) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $13
    • NextDecade (NEXT) downgraded to Neutral from Outperform at Credit Suisse; tgt raised to $7.50
    • Poshmark (POSH) downgraded to Hold from Buy at Stifel; tgt lowered to $15
    • Qorvo (QRVO) downgraded to Neutral from Outperform at KGI Securities; tgt $140
    • Science Applications (SAIC) downgraded to Hold from Buy at Truist; tgt $105
    • Silverback Therapeutics (SBTX) downgraded to Hold from Buy at Stifel; tgt lowered to $6
    • Silverback Therapeutics (SBTX) downgraded to Neutral from Buy at H.C. Wainwright
    • UniFirst (UNF) downgraded to Underweight from Neutral at JP Morgan; tgt $178
    • Urban Outfitters (URBN) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $29
    • Walgreens Boots Alliance (WBA) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $51
    • Wayfair (W) downgraded to Underweight from Equal Weight at Barclays; tgt $103
    • Zimmer Biomet (ZBH) downgraded to Neutral from Buy at Citigroup; tgt raised to $135
  • Others:
    • 1Life Healthcare (ONEM) assumed with an Outperform at Credit Suisse; tgt $15
    • Accolade (ACCD) assumed with an Outperform at Credit Suisse; tgt $33
    • Agree Realty (ADC) initiated with an Overweight at Morgan Stanley; tgt $75
    • AmerisourceBergen (ABC) assumed with an Outperform at Credit Suisse; tgt $180
    • Amwell (AMWL) assumed with a Neutral at Credit Suisse; tgt $5
    • Cano Health (CANO) assumed with an Outperform at Credit Suisse; tgt $13
    • Cardinal Health (CAH) assumed with a Neutral at Credit Suisse; tgt $58
    • Change Healthcare (CHNG) assumed with a Neutral at Credit Suisse; tgt $25.75
    • Check Point Software (CHKP) initiated with a Buy at Summit Insights; tgt $160
    • Definitive Healthcare (DH) assumed with a Neutral at Credit Suisse; tgt $24
    • eHealth (EHTH) assumed with a Neutral at Credit Suisse; tgt $16
    • Edwards Lifesciences (EW) added to Focus List at Citigroup
    • GoHealth (GOCO) assumed with an Underperform at Credit Suisse; tgt $1.50
    • GoodRx (GDRX) assumed with a Neutral at Credit Suisse; tgt $22
    • Hims & Hers Health (HIMS) assumed with an Outperform at Credit Suisse; tgt $8
    • ImaRx Therapeutics (IMRX) initiated with an Outperform at Oppenheimer; tgt $25
    • McKesson (MCK) assumed with an Outperform at Credit Suisse; tgt $333
    • MSCI (MSCI) initiated with a Neutral at Goldman; tgt $553
    • Oracle (ORCL) initiated with a Neutral at Daiwa Securities; tgt $87
    • Owens & Minor (OMI) assumed with a Neutral at Credit Suisse; tgt $43
    • Premier (PINC) assumed with an Underperform at Credit Suisse; tgt $35
    • Privia Health (PRVA) assumed with an Outperform at Credit Suisse; tgt $43
    • Rain Therapeutics (RAIN) initiated with an Outperform at Oppenheimer; tgt $15
    • SelectQuote (SLQT) assumed with a Neutral at Credit Suisse; tgt $4
    • Snowflake (SNOW) initiated with a Neutral at SMBC Nikko; tgt $253
    • SOC Telemed (TLMD) assumed with a Neutral at Credit Suisse; tgt $3
    • Teladoc (TDOC) assumed with an Outperform at Credit Suisse; tgt $114
    • Tivity Health (TVTY) assumed with a Neutral at Credit Suisse; tgt $31
    • Upstart (UPST) initiated with an Equal-Weight at Stephens; tgt $124
    • Vectrus (VEC) initiated with a Buy at Truist; tgt $65

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • RDW -16.9%, BLND -16%, DCT -11.4%, BB -4%, WEJO -3.2%, ASTS -1.4%

Other news:

  • SLS -22.5% (signs license agreement with GenFleet Therapeutics for GFH009; prices offering of 4629630 shares of its common stock and accompanying warrants to purchase up to 4629630 shares of common stock at a combined public offering price of $5.40 per share and accompanying warrant)
  • SPRO -19.5% (FDA identifies deficiencies in Spero's NDA for tebipenem)
  • ALE -5.6% (prices offering of 3.2 mln shares of common stock at $63.00 per share)
  • IIPR -3.6% (commences public offering of 1 mln shares)
  • ATCX -2.1% (stock offering)

Analyst comments:

  • AMLX -3.4% (downgraded to Neutral from Buy at Goldman)
  • W -2.5% (downgraded to Underweight from Equal Weight at Barclays)
  • COMM -2.3% (downgraded to Neutral from Buy at Goldman)
  • DELL -0.9% (downgraded to Neutral from Conviction Buy at Goldman)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • INDI +5%, NCNO +4.9% (also WFC will expand use of nCino Bank OS to accelerate its digital transformation), SAN +3.3% (reaffirms FY22 targets), PL +3.1%, HYMC +2.2%, VLTA +1.6%, PNC +0.7%

Other news:

  • GME +15.5% (to seek approval for 3.33-for-1 stock split)
  • SAGE +10.3% (announces presentation of promising results from the Phase 2 LUMINARY Study of SAGE-718 in patients with mild cognitive impairment and mild dementia due to Alzheimer's Disease)
  • BZUN +9.4% (announces repurchase right notification for 1.625% Convertible Senior Notes due 2024)
  • XPEV +8.7% (announces vehicle delivery results for march and first quarter 2022; 34561 vehicles delivered in Q1 2022 a 159% increase yr/yr)
  • XSPA +7.1% (stock offering)
  • NIO +6% (provides March and Q1 delivery update)
  • LI +5.7% (reports March deliveries increased 125.2% yr/yr)
  • PHAR +5.7% (positive data from Phase II/III leniolisib trial presented)
  • CLNN +5.6% (along with its subsidiaries "Clene" and its wholly owned subsidiary Clene Nanomedicine announce new data from the open-label extension of RESCUE-ALS)
  • KOS +4.6% (successfully refinances credit facility)
  • FSR +3.1% (passes 40000 initial reservations for Fisker Ocean SUV)
  • GRIN +3% (CEO to retire)
  • LEV +3% (receives purchase order for 30 school buses)
  • HLX +2.1% (enters into new contract with Shell Offshore to provide well intervention services)
  • RETA +2% (completes rolling submission of NDA for omaveloxolone for Friedreich's ataxia)
  • GTHX +1.8% (reports results of real world study of trilaciclib)
  • HOOD +1.7% (nearing launch of retirement account support on its platform according to Bloomberg)
  • PPGH +1.7% (receives shareholder approval for combination with Gogoro)
  • VMI +1% (enters into a $209 mln supply agreement with Siemens Gamesa for wind market)

Analyst comments:

  • TELL +7.2% (upgraded to Outperform from Neutral at Credit Suisse)

FT : European gas buyers have at least 2 weeks to pay in roubles, says Kremlin

European gas buyers have at least 2 weeks to pay in roubles, says Kremlin
Threat of supply cut-off remains as Moscow demands payment in local currency

European importers of Russian natural gas have until at least the second half of April to comply with Moscow’s demand that they pay in roubles, the Kremlin said, as buyers struggle to understand their obligations.

“Payment for the actual deliveries that are going on now does not need to be made today,” said Dmitry Peskov, the Kremlin’s spokesman, on Friday, the day after Russia published a decree on rouble payments.

“It should be made somewhere . . . in the second half of the month of April, or even at the beginning of May.”

His comments eased fears that Russia could immediately shut off supplies to any buyer that did not offer roubles. But the longer-term threat remains of Moscow halting deliveries and starving parts of Europe of energy.

Multiple European buyers have so far refused to pay in roubles, saying that Russia’s demand breaches the terms of their purchase contracts, which are mostly denominated in euros or US dollars.

Russia proposed a mechanism that would require gas buyers to open bank accounts both in foreign currency and roubles at Gazprombank, which is not subject to EU sanctions, in order to buy roubles to use for payment. It said doing so would not violate contracts or change volume or pricing terms.

Russia’s president Vladimir Putin signed the rouble decree on Thursday. It applies to “unfriendly” countries that have imposed sanctions on Russia over the invasion of Ukraine, including EU members.

If payments were not made, he said, “we will consider this a default on the part of the buyers — with all the ensuing consequences”.

The threat of supply disruptions has triggered alarm among European countries that rely heavily on Russian gas, with Germany and Austria this week beginning to prepare for energy rationing.

Olaf Scholz, Germany’s chancellor, said on Thursday he had told Putin that his country had checked its gas contracts with Russia and would keep paying for them in euros and sometimes dollars.

Putin described the proposed payments mechanism as “a clear and transparent scheme” for foreign customers.

But Laurent Ruseckas, an energy analyst at S&P Global, said one concern for European gas buyers was that the Russian central bank — which is under sanctions, unlike Gazprombank — would likely be the de facto counterparty for rouble exchanges.

“The objections are more likely to come from the political level,” he said, but added: “There’s potential for a compliance issue for companies.”

Gazprom, the country’s gas giant that supplies more than a third of Europe’s gas needs, said on Friday it had started sending out formal notifications to its clients about the new payment process.

“Gazprom, as a Russian company, unconditionally and fully complies with the requirements of Russian legislation,” it said in a statement. “Notifications about the new procedure for settlements in Russian roubles are officially sent today to counterparties.” It added that it continued to “reliably export” gas.

OMV, an Austrian buyer of Russian gas, confirmed that state-owned Gazprom had been in touch for the first time about the change in payment to roubles but said it was awaiting written information from its contractual partner.

Slovakia’s SPP, another big buyer of Russian gas, said: “None of our suppliers has contacted us in this matter. SPP will act fully in line with terms and conditions of the respective contracts. The current currency for gas supplies is the euro.”

>>> US Early premarket gappers


Early premarket gappers

  • Gapping up:
    • GME +14.6%, XSPA +7.1%, LI +5.6%, KOS +5.6%, BZUN +4.9%, HITI +4.6%, HYMC +3.9%, INDI +3.7%, NCNO +3.7%, FSR +3.6%, LEV +3.1%, PL +3.1%, OLN +3%, MAG +2.8%, HOOD +2.7%, GRIN +2.3%, RETA +2.1%, GTHX +1.8%, PPGH +1.7%, RTX +1.6%, HLX +1.5%, VMI +1%, VLTA +1%, AMZN +0.9%
  • Gapping down:
    • BLND -24.9%, SPRO -24.1%, SLS -24%, RDW -23.5%, DCT -12.3%, WEJO -7.9%, ALE -5.9%, RNGR -3.5%, ASTS -3%, BB -2.7%, IIPR -2.1%, ATCX -2.1%, CE -0.5%